袢利尿剂治疗伴或不伴心力衰竭对预后的影响
结果显示,无心衰记录但使用袢利尿剂者五年死亡率为40%(adjHR 1.8),高于有心衰记录但未用利尿剂者的22%(adjHR 1.2),心衰合并利尿剂治疗者最高为52%(adjHR 2.2)。结论提示死亡率与袢利尿剂使用的关联强于与心衰诊断记录的关联。
要点
- 无心衰诊断记录但使用袢利尿剂者占12%,其五年死亡率达40%,显著高于参照组。
- 心衰合并袢利尿剂治疗者五年死亡率最高(52%,adjHR 2.2),预后最差。
- 死亡率与袢利尿剂使用的关联强于与心衰诊断记录的关联,提示可能存在诊断遗漏或不适宜用药。
核心结论
- 在心血管疾病患者中,死亡率与袢利尿剂使用的关联强于与心衰诊断记录的关联,可能反映心衰诊断遗漏、袢利尿剂相关其他疾病或用药不当。
研究设计与样本
- 采用Cox模型分析结局,校正年龄、性别、社会经济剥夺和合并疾病(adjHR)。
主要发现
- 有心衰记录且使用袢利尿剂者7844例(4%),五年死亡率为52%,adjHR 2.2(95% CI 2.0-2.2)。
- 有心衰记录但未用袢利尿剂者5156例(3%),五年死亡率为22%,adjHR 1.2(95% CI 1.1-1.3)。
临床怎么用
- 对无明确心衰诊断但长期使用袢利尿剂的心血管病患者,应重新评估心衰诊断及用药指征。
- 袢利尿剂使用可作为预后风险增高的提示信号,需加强此类患者的随访管理。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: Many patients are prescribed loop diuretics without a diagnostic record of heart failure. Little is known about their characteristics and prognosis. METHODS: Glasgow regional health records (2009-16) were obtained for adults with cardiovascular disease or taking loop diuretics. Outcomes were investigated using Cox models with hazard ratios adjusted for age, sex, socioeconomic deprivation, and comorbid disease (adjHR). RESULTS: Of 198 898 patients (median age 65 years; 55% women), 161 935 (81%) neither took loop diuretics nor had a diagnostic record of heart failure (reference group), 23 963 (12%) were taking loop diuretics but had no heart failure recorded, 7844 (4%) had heart failure recorded and took loop diuretics, and 5156 (3%) had heart failure recorded but were not receiving loop diuretics. Compared to the reference group, five-year mortality was only slightly higher for heart failure in the absence of loop diuretics [22%; adjHR 1.2 (95% CI 1.1-1.3)], substantially higher for those taking loop diuretics with no record of heart failure [40%; adjHR 1.8 (95% CI 1.7-1.8)], and highest for heart failure treated with loop diuretics [52%; adjHR 2.2 (95% CI 2.0-2.2)]. CONCLUSIONS: For patients with cardiovascular disease, many are prescribed loop diuretics without a recorded diagnosis of heart failure. Mortality is more strongly associated with loop diuretic use than with a record of heart failure. The diagnosis of heart failure may be often missed, or loop diuretic use is associated with other conditions with a prognosis similar to heart failure, or inappropriate loop diuretic use increases mortality; all might be true.
引用
- Friday, Cleland, Pellicori, et al. Loop diuretic therapy with or without heart failure: impact on prognosis. Eur Heart J. 2024. PMID: 38845446. doi:10.1093/eurheartj/ehae345
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。